The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Nectar Lifesciences Ltd

Nectar Lifesciences Ltd

BSE 532649 · NSE NECLIFE · ISIN INE023H01027 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹13.11

+4.55%

BSE close, 28 August 2026

Market cap

₹254.68 cr

19.4 cr shares · Micro cap

Free float

₹122.65 cr

as published

P/E · P/B

-1.1× · 0.24×

EPS ₹-12.50 · BV ₹54.62

FY25-26 rev / PAT

— / -292.89

₹ cr, as filed

Filings, window

16

3 selected · 19%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹9.20 52-WK HIGH ₹22.49 ₹13.11 29% of range
Against 52-week high-41.7%
Against 52-week low+42.5%
Day change+4.55%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-12.50
Price / earnings-1.05×
Price / book0.24×
Book value — derived, price ÷ P/B₹54.62
Return on equity-22.53%
Operating margin-142,580.00%
Net margin-87,566.67%

Consistency check

P/B ÷ P/E, which must equal ROE
-22.86%
ROE as published
-22.53%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 0.02 -13.14 -0.69 -142,580.00% -87,566.67%
Mar-26 · Q — -67.92 -1.85 — —
FY25-26 — -292.89 -2.62 — —

Quarter on quarter

Net profit, quarter on quarter
+80.7%

Disclosure profile 16 filings in the window

0 median 17.0 p75 · 25 sector max 52 16 47th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Resignation1
Results1
Selected sub-total3
Procedural
AGM / EGM4
General2
Newspaper Publication2
Annual Report1
Board Meeting1
Book Closure1
Compliance Certificate1
Trading Window1
Procedural sub-total13
Total16

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

16 filings · 3 selected · busiest 2026-08-14 and 2026-08-20

Filing rhythm · the twelve most recent

2026-08-142026-10-06

SelectedProcedural

Filings

16 in the window · 2 earlier on record

  1. 6 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find attached herewith certificate as per caption regulations

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 5 October 2026 ·

    AGM / EGM

    Minutes Of 31St Annual General Meeting ("AGM")

    Please find attached herewith copy of minutes of 31st AGM of the Company.

    AGM/EGM / AGM View filing →

  3. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    Trading window closure pursuant to SEBI ( Prohibition of Insider Trading) Regulations, 2015

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 18 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find attached herewith outcome of Annual General Meeting held on September 18, 2026 with a copy Scrutinizer report and voting results.

    AGM/EGM / AGM View filing →

  5. 18 September 2026 ·

    AGM / EGM

    Proceedings Of 31St Annual General Meeting ('AGM')

    Please find attached herewith Proceedings of 31st AGM

    AGM/EGM / AGM View filing →

  6. 21 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find attached herewith newspaper publication of notice of 31st Annual General Meeting, e-voting, book closure & other information.

    Company Update / Newspaper Publication View filing →

  7. 20 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual ....

    Others / Reg. 34 (1) Annual Report View filing →

  8. 20 August 2026 ·

    AGM / EGM

    Notice Of 31St Annual General Meeting ('AGM') For The Financial Year 2025-26

    Please find attached herewith Notice of 31st AGM for the Financial Year 2025-26 is scheduled to be held on Friday, September 18, 2026

    AGM/EGM / AGM View filing →

  9. 20 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find attached herewith newspaper publication of notice to the shareholders regarding 31st AGM of the Company to be held on Friday, September 18, 2026, through Video Conferencing ....

    Company Update / Newspaper Publication View filing →

  10. 14 August 2026 ·

    Book Closure

    Book Closure/ Cut-Off Date For The Purpose Of 31St Annual General Meeting ('AGM') For The Financial Year ('FY') 2025-26

    AGM to be held on September 18, 2026 and book closure date for the same is from September 12, 2026 to September 18, 2026(both days inclusive). The Cut-off date, to ascertain the eligibility ....

    Corp. Action / Book Closure View filing →

  11. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for 31St Annual General Meeting ("AGM") To Be Held On 18-09-2026 And Other Business Matters.

    We wish to inform you that the board of directors of Nectar Lifesciences Limited ('Company') in their meeting held on August 14, 2026, have, inter-alia, noted, decided and approved the ....

    Board Meeting / Outcome of Board Meeting View filing →

  12. 14 August 2026 ·

    Results

    Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30, 2026

    Please find attached herewith the financial results for the quarter ended on June 30, 2026.

    Result / Financial Results View filing →

  13. 10 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Financial Results And Other Business Matters.

    Nectar Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

  14. 6 August 2026 ·

    Resignation

    Resignation of Director

    Please find attached herewith letter of Resignation of Non-Executive Non-Independent Director of the Nectar Lifesciences Limited

    Company Update / Resignation of Director View filing →

  15. 4 August 2026 ·

    General

    Sale And Surrender Of Leasehold Rights In Land Situated In Jammu

    Please find attached herewith letter of Sale and Surrender of Leasehold Rights in Land Situated in Jammu

    Company Update / General View filing →

  16. 23 July 2026 ·

    General

    Update On Slump Sale

    Please find attached herewith letter w.r.t.: Update on Slump Sale

    Company Update / General View filing →

RSS feed for Nectar Lifesciences Ltd · the 50 most recent filings